Quality of Life Research

, Volume 7, Issue 2, pp 143–153 | Cite as

The international development of the RGHQoL: a quality of life measure for recurrent genital herpes

  • L. C Doward
  • S. P McKenna
  • T Kohlmann
  • M Niero
  • D Patrick
  • B Spencer
  • H. Thorsen

Abstract

This paper describes the international development and psychometric testing of the Recurrent Genital Herpes Quality of Life Questionnaire (RGHQoL), a condition-specific quality of life (QoL) instrument. The theoretical foundation for the measure is the needs-based model of QoL and the content of the instrument was derived from in-depth qualitative interviews with relevant patients in the UK. Versions of the RGHQoL were required for the UK, USA, Italy, Germany, France and Denmark for use in international clinical trials. The results indicate that the final 20 item measure has good reliability, internal consistency and validity for all language versions. A small responsiveness study in Denmark suggested that the measure is sensitive to changes in QoL associated with the initiation of suppression treatment for recurrent genital herpes (RGH). It is concluded that the RGHQoL is a valuable instrument for inclusion in clinical trials. The psychometric properties of the instrument are such that it may also be used to monitor the progress of individual patients.

Quality of life questionnaire recurrent genital herpes. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hunt SM, Kovachich P, McKenna SP. Genital herpes and quality of life. Br J Sexual Med 1993; 20: January/February: 12-15.Google Scholar
  2. 2.
    Kinghorn GR. Epidemiology of genital herpes. J Int Med Res 1994; 22(Suppl): 14A-23A.Google Scholar
  3. 3.
    Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and-sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; 69(Suppl): 19-36Google Scholar
  4. 4.
    Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Commun Health 1989; 43(1): 53-60.Google Scholar
  5. 5.
    Prober CG, Corey L, Brown ZA et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992; 15(6): 1031-1038.Google Scholar
  6. 6.
    Boulos R, Ruff AJ, Nahmias A et al. Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type I infections. J Infect Dis 1992; 166(2): 418-420.Google Scholar
  7. 7.
    Mertz GJ. Epidemiology of genital herpes infections. STDs AIDS Era 1993; 7(4): 825-839.Google Scholar
  8. 8.
    McKenna SP, Doward LC. Measuring quality of life in recurrent genital herpes. Eur Rev Appl Psychol 1995; 45(4): 289-294.Google Scholar
  9. 9.
    Mindel A, Carney O. Herpes: What it is and How to Cope. London: MacDonald Optima, 1991.Google Scholar
  10. 10.
    Bierman S. Recurrent genital herpes simplex infection: a trivial disorder. Arch Dermatol 1985; 121: 513-517.Google Scholar
  11. 11.
    Luby ED, Klinge V. Genital herpes. A pervasive psychosocial disorder. Arch Dermatol 1985; 121: 494-497.Google Scholar
  12. 12.
    Doward LC. Developing a measure of quality of life for patients with recurrent genital herpes. Drug Informat J 1994; 28: 19-25.Google Scholar
  13. 13.
    Goldmeier D, Johnson A, Byrne M et al. Psychological implications of recurrent genital herpes. Genitourinary Med 1988; 64: 327-330.Google Scholar
  14. 14.
    Carney O. Psychosocial/Psychosexual aspects of genital herpes. In: A Conference on Recurrent Genital Herpes. A Management Focus. Paris: The Wellcome Foundation.Google Scholar
  15. 15.
    Drob S, Loemer M, Lifshutz H. Genital herpes. The psychological consequences. Br J Med Psychol 1985; 58: 307-315.Google Scholar
  16. 16.
    Streiner D, Norman G. Health Measurement Scales. Oxford: Oxford University Press, 1989.Google Scholar
  17. 17.
    Hunt SM, McKenna SP. The QLDS. A scale for the measurement of quality of life in depression. Health Policy 1992; 22: 307-319.Google Scholar
  18. 18.
    McKenna SP, Hunt SM. A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 1992; 22: 321-330.Google Scholar
  19. 19.
    Hunt SM, McKenna SP, Doward LC. Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinol 1993; 128(Suppl 2): 37-40.Google Scholar
  20. 20.
    McKenna SP, Doward LC. Quality of life assessment of adults with growth hormone deficiency: implications for drug therapy. PharmacoEconomics 1994; 6(5): 434-441.Google Scholar
  21. 21.
    Holmes SJ, McKenna SP, Doward LC, Shalet SM. Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinol Metab 1995; 2: 63-69.Google Scholar
  22. 22.
    Wagner TH, Patrick DL, McKenna SP, Froese PS. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1995; 4: 500-501.Google Scholar
  23. 23.
    McKenna SP, Patrick D. The development of a migraine-specific quality of life measure for multi-national clinical trials. Cephalalgia 1995; 15(Suppl 14): 280.Google Scholar
  24. 24.
    Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997; 36: 884-888.Google Scholar
  25. 25.
    de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997; 36: 878-883.Google Scholar
  26. 26.
    Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res 1993; 2: 367-368.Google Scholar
  27. 27.
    Jachuck SJ, Brierley H, Jachuk S, Willcox P. The effect of hypertensive drugs on the quality of life. J R Coll Gen Practitioners 1982; 32: 103-105.Google Scholar
  28. 28.
    Hunt SM, Alonso J, Bucquet D et al. Cross-cultural adaptation of health measures. Health Policy 1991; 19: 33-44.Google Scholar
  29. 29.
    Weiner E, Stewart B. Assessing Individuals. Boston: Little Brown, 1984.Google Scholar
  30. 30.
    Kohlmann T, Bullinger M, Kirchberger-Blumstein I. Die deutche Version des Nottingham Health Profile (NHP): Übersetzungsmethodik und psychometrische Validierung. Sozial-und Präventivmedizin 1997; 42: 175-185.Google Scholar

Copyright information

© Chapman and Hall 1998

Authors and Affiliations

  • L. C Doward
    • 1
  • S. P McKenna
    • 1
  • T Kohlmann
    • 2
  • M Niero
    • 3
  • D Patrick
    • 4
  • B Spencer
    • 5
  • H. Thorsen
    • 6
  1. 1.Galen ResearchManchesterUK
  2. 2.Institut für SozialmedizinMedizinische Universität LübeckLübeckGermany
  3. 3.University of VenicePadovaItaly
  4. 4.School of Public Health and Community MedicineUniversity of WashingtonSeattleUSA
  5. 5.Institut Universitaire de Medicine Sociale et PreventiveLausanneSwitzerland
  6. 6.Department of General PracticeUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations